1. Harnessing mesenchymal stem cell homing as an anticancer therapy
    Anna Hagenhoff et al, 2016, Expert Opinion on Biological Therapy CrossRef
  2. Bone Marrow-Derived Mesenchymal Stem Cells Expressing Thioredoxin 1 Attenuate Bleomycin-Induced Skin Fibrosis and Oxidative Stress in Scleroderma
    Miao Jiang et al, 2017, Journal of Investigative Dermatology CrossRef
  3. Pigment epithelium-derived factor and its role in microvascular-related diseases
    Yuzhuo Wang et al, 2022, Biochimie CrossRef
  4. Genistein inhibits A549 human lung cancer cell proliferation via miR-27a and MET signaling
    Yang Yang et al, 2016, Oncology Letters CrossRef
  5. The secretion profile of mesenchymal stem cells and potential applications in treating human diseases
    Yuyi Han et al, 2022, Signal Transduction and Targeted Therapy CrossRef
  6. Effects of pigment epithelium derived factor (PEDF) on malignant peripheral nerve sheath tumours (MPNSTs)
    Maria Demestre et al, 2013, Journal of Neuro-Oncology CrossRef
  7. Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases. Comprehensive Review of the Recent Literature 2010–2012
    Daniel J. Weiss, 2013, Annals of the American Thoracic Society CrossRef
  8. Mesenchymal stem cells: A living carrier for active tumor-targeted delivery
    Tianyuan Zhang et al, 2022, Advanced Drug Delivery Reviews CrossRef
  9. Mesenchymal stem cells in lung cancer tumor microenvironment: their biological properties, influence on tumor growth and therapeutic implications
    Renwang Liu et al, 2014, Cancer Letters CrossRef
  10. Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment
    Daria S. Chulpanova et al, 2018, Frontiers in Pharmacology CrossRef
  11. Mesenchymal Stem Cells as Vectors for Cancer Therapy
    Phuc Van Pham et al, 2018, Stem Cells for Cancer and Genetic Disease Treatment CrossRef
  12. The therapeutic potential of mesenchymal stem cells in lung cancer: benefits, risks and challenges
    Lourdes Cortes-Dericks et al, 2019, Cellular Oncology CrossRef
  13. Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice
    Alexandros Stamatopoulos et al, 2019, Journal of Bone Oncology CrossRef
  14. Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic
    Hong-Hui Wu et al, 2019, Journal of Controlled Release CrossRef
  15. Therapeutic Potential of Pigment Epithelium-derived Factor in Cancer
    Sho-ichi Yamagishi et al, 2019, Current Pharmaceutical Design CrossRef
  16. The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential
    S. Patricia Becerra et al, 2013, Nature Reviews Cancer CrossRef
  17. Proapoptotic PEDF functional peptides inhibit prostate tumor growth—A mechanistic study
    Qing Gong et al, 2014, Biochemical Pharmacology CrossRef
  18. The future of mesenchymal stem cell-based therapeutic approaches for cancer – From cells to ghosts
    Andrea Mohr et al, 2018, Cancer Letters CrossRef
  19. Genetically-modified Stem Cell in Regenerative Medicine and Cancer Therapy; A New Era
    Javad Verdi et al, 2021, Current Gene Therapy CrossRef
  20. Anti-angiogenesis gene therapy for hepatocellular carcinoma via systemic injection of mesenchymal stem cells engineered to secrete soluble Flt-1
    Guanglin Li et al, 2017, Molecular Medicine Reports CrossRef
  21. Genetically modified mesenchymal stromal cells in cancer therapy
    Elizabeth K. Sage et al, 2016, Cytotherapy CrossRef
  22. Current progress in engineered and nano-engineered mesenchymal stem cells for cancer: From mechanisms to therapy
    Forough Shams et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  23. Targeted delivery in scleroderma fibrosis
    Carla Varrica et al, 2021, Autoimmunity Reviews CrossRef